Tci Wealth Advisors, Inc. Iovance Biotherapeutics, Inc. Transaction History

Tci Wealth Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$5.53 - $8.22 $3,069 - $4,562	555 New	555 $3,000
Q2 2022 Jul 19, 2022	BUY	$6.38 - $18.33 $2,730 - $7,845	428 Added 1126.32%	466 $5,000
Q1 2022 Apr 29, 2022	BUY	$12.38 - $19.1 $470 - $725	38 New	38 $1,000
Q3 2021 Oct 29, 2021	SELL	$20.35 - $26.63 $345 - $452	-17 Closed	0 $0
Q1 2021 Apr 29, 2021	SELL	$28.67 - $52.59 $28 - $52	-1 Reduced 5.56%	17 $1,000
Q2 2020 Jul 20, 2020	BUY	$27.21 - $41.0 $489 - $738	18 New	18 $0

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.24B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.